Skip to content
10-Q

Quarterly Report

Panacea Life Sciences Holdings, Inc. PLSH

0001493152-22-031530

← back to feed
Filed
Nov 14, 2022 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2022 · Nov 2, 2022 14.97M sh
Cash And Equivalents Q3 2022 · Sep 30, 2022 $36.79K
Cash And Equivalents Q3 2022 · Dec 31, 2021 $19.77K
Current Liabilities Q3 2022 · Sep 30, 2022 $13.81M
Current Liabilities Q3 2022 · Dec 31, 2021 $10.07M
Total Liabilities Q3 2022 · Sep 30, 2022 $20.42M
Total Liabilities Q3 2022 · Dec 31, 2021 $16.68M
Current Assets Q3 2022 · Sep 30, 2022 $6.48M
Current Assets Q3 2022 · Dec 31, 2021 $9.1M
Total Assets Q3 2022 · Sep 30, 2022 $19.98M
Total Assets Q3 2022 · Dec 31, 2021 $23.78M
Revenue Q3 2022 · Sep 30, 2021 $588.04K
Revenue Q3 2022 · Sep 30, 2021 $1.41M